ERBB2 and neoplasm: Of note, DCIS-Mi tumors tended to exhibit the highest proportion of human epidermal growth factor receptor2 (HER2)-positive tumor (29.5% for DCIS, 42.9% for DCIS-Mi and 29.3% for DCIS-T1a, P=0.048).